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It has been suggested that skeletal muscle mitochondria play a key role in high
fat (HF) diet induced insulin resistance (IR). Two opposite views are debated on
mechanisms by which mitochondrial function could be involved in skeletal muscle IR.
In one theory, mitochondrial dysfunction is suggested to cause intramyocellular lipid
accumulation leading to IR. In the second theory, excess fuel within mitochondria in
the absence of increased energy demand stimulates mitochondrial oxidant production
and emission, ultimately leading to the development of IR. Noteworthy, mitochondrial
bioenergetics is strictly associated with the maintenance of normal mitochondrial
morphology by maintaining the balance between the fusion and fission processes.
A shift toward mitochondrial fission with reduction of fusion protein, mainly mitofusin
2, has been associated with reduced insulin sensitivity and inflammation in obesity
and IR development. However, dietary fat source during chronic overfeeding differently
affects mitochondrial morphology. Saturated fatty acids induce skeletal muscle IR and
inflammation associated with fission phenotype, whereasω-3 polyunsaturated fatty acids
improve skeletal muscle insulin sensitivity and inflammation, associated with a shift
towardmitochondrial fusion phenotype. The presentminireview focuses onmitochondrial
bioenergetics and morphology in skeletal muscle IR, with particular attention to the
effect of different dietary fat sources on skeletal muscle mitochondria morphology and
fusion/fission balance.
Keywords: mitochondrial fusion, mitochondrial fission, lard, fish oil, omega-3 fatty acids
INTRODUCTION
Skeletal muscle seems to play a central role in whole body insulin resistance (IR) and metabolic
syndrome associated with high fat (HF) feeding, obesity and aging (see Corpeleijn et al., 2009;
DeFronzo and Tripathy, 2009; Lark et al., 2012).
Some evidence suggested that cytosolic ectopic accumulation of fatty acids (FA) metabolites,
such as diacylglycerols (DAG) and/or Ceramides, (Yu et al., 2002; Adams et al., 2004), underlies
IR development in skeletal muscle (lipotoxicity theory) (reviewed in Lark et al., 2012). Numerous
evidence has also suggested a link between elevated systemic and tissue inflammation with IR
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(inflammatory theory) (see Shenk et al., 2008; Lark et al.,
2012). The effectors of IR in HF diet-induced inflammation are
suggested to involve hyperactivation of stress-sensitive Ser/Thr
kinases, such as JNK and IKKβ, which in turn inhibits insulin
receptor/IRS1 axis. Several mechanisms were proposed to explain
the link between inflammation and IR: endoplasmic reticulum
(ER) stress (Ozcan et al., 2004; Lionetti et al., 2009; Mollica
et al., 2011), oxidative stress (Lark et al., 2012), signaling through
inflammation-associated receptors, such as TLR4 signaling
(Uysal et al., 1997; Shi et al., 2006), and partitioning/activation of
c-SRC (a keymediator of JNK activation) by saturated FA (Holzer
et al., 2011; Figure 1A).
In recent years, different reviews focused on mechanism(s) by
which mitochondrial bioenergetics (Fisher-Wellman and Neufer,
2012; Lark et al., 2012; Muoio and Neufer, 2012; Holloszy,
2013) and morphology (Liesa and Shirihai, 2013; Montgomery
and Turner, 2015) may be linked to the etiology of IR in
skeletal muscle. In the present review, the challenging debate
on the involvement of mitochondrial dysfunction in IR will
be briefly reviewed. Then, the main aim of the review will
be to underline the importance of including mitochondrial
morphology/dynamics and dietary fat source in the debate on
skeletal muscle mitochondria involvement in IR etiology and
to highlight the need of further research studies to clarify the
involved mechanism(s).
SKELETAL MUSCLE MITOCHONDRIAL
BIOENERGETICS AND IR
Two leading theories on mechanisms underlying skeletal muscle
IR onset focus on mitochondria, although with opposite
views (Figure 1B). In one theory, mitochondrial dysfunction is
suggested to cause intramyocellular lipid accumulation leading
to IR (Kelley et al., 1999; Lowell and Shulman, 2005; reviewed
in Civitarese and Ravussin, 2008; Montgomery and Turner,
2015). In this case, the strategies to accelerate flux through
β-oxidation should improve insulin sensitivity. In the second
theory, excess fuel within mitochondria in the absence of
increased energy demand stimulates mitochondrial oxidant
production and emission, ultimately leading to the development
of IR (Fisher-Wellman andNeufer, 2012; Figure 1B). In this case,
elevated flux through β-oxidation without added energy demand
is viewed as an underlying cause of IR disease (Muoio andNeufer,
2012).
Several studies have revealed a reduction in skeletal
mitochondrial mass in obesity and type 2 diabetes (Kelley
et al., 2002; Morino et al., 2005; Ritov et al., 2005), decreased
ATP synthesis in insulin resistant offspring of patients with type
2 diabetes (Petersen et al., 2004, 2005) and decreased maximal
respiration rates in skeletal muscle isolated mitochondria from
type 2 diabetics (Mogensen et al., 2007). Moreover, with the
limitation that gene expression is not a direct assessment
of function itself, HF diet has been shown to coordinately
down-regulate genes required for mitochondrial oxidative
phosphorylation in human and rodents skeletal muscle (Sparks
et al., 2005). Interestingly, in skeletal muscle from obese or
diabetic patients, decreased activity of electron transport
chain and reduced number of mitochondria have been mainly
reported in skeletal muscle mitochondria located beneath
the sarcolemmal membrane (SS mitochondria) (Ritov et al.,
2005). SS mitochondria also displayed lower respiratory
capacities in presence of succinate as substrates in adult rats
exhibiting HF diet-induced IR (Lionetti et al., 2007). The two
mitochondrial subpopulations (SS and intermyiofibrillar, IMF)
are differentiated not only by the different localization but also by
the different functions (Cogswell et al., 1993; Mollica et al., 2006):
SS mitochondria could be more affected by the impairing effect
of saturated FA due to their localization beneath the sarcolemmal
membrane.
However, although correlative studies seem to implicate
mitochondrial dysfunction and impaired β-oxidation as
predisposing risk factors for IR, still uncertain is whether
diminished fat oxidation reflects a cause or a late stage
consequence of the disease process (reviewed in Muoio, 2010).
In fact, obese/diabetic humans never use their mitochondrial
capacity for lipid oxidation; therefore, a marginal decline in
oxidative potential has little relevance in causing lipotoxicity
and IR in sedentary individuals. Moreover, it has been suggested
that early stages of obesity and IR are accompanied by increased,
rather than reduced β-oxidation (Muoio, 2010). These findings
question the concept that mitochondrial dysfunction is a primary
cause of IR (Hoeks et al., 2010, 2011), as also underscored by
the study of Bonnard et al. (2008), showing mitochondrial
dysfunction in skeletal muscle after 16 weeks, but not after 4
weeks HF feeding, while muscle IR was observed after both 4 and
16 weeks of HF feeding. In addition, mitochondrial deficiency,
severe enough to impair fat oxidation in resting muscle, cause an
increase, not a decrease, in insulin action (reviewed in Holloszy,
2013). Altogether, these studies suggest that deficiency of
mitochondria in muscle does not cause IR (reviewed in Holloszy,
2013).
An alternative mechanism to explain the connection between
mitochondria and IR focused on reactive oxygen species
(ROS) production (reviewed in Muoio and Neufer, 2012;
Holloszy, 2013). Lefort et al. (2010) showed normal oxidative
capacity, decreased mitochondrial mass and high rates of
ROS production in mitochondria isolated from skeletal muscle
of obese insulin resistant individuals. Moreover, FA overload
within the mitochondria results in the accumulation of partially
oxidized acyl-carnitines, increased mitochondrial hydrogen
peroxide (H2O2) emission and a shift to a more oxidized
intracellular redox environment (Anderson et al., 2009; reviewed
in Lark et al., 2012). H2O2 emission may induce IR by
directly targeting protein involved in the glucose uptake
process. On the other hand, given the sensitivity of cellular
phosphatase to redox state, it has been suggested that elevated
mitochondrial H2O2 production may decrease phosphatase tone
in cells, increasing the inhibition state of insulin signaling
proteins by stress-sensitive kinases (reviewed in Lark et al.,
2012).
Although the primary role of skeletal muscle mitochondrial
dysfunction in the pathogenesis of IR and type 2 diabetes
is under debate (Hoeks et al., 2010, 2011; Holloszy,
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FIGURE 1 | Mechanism linking excess fatty acids to insulin resistance in skeletal muscle. (A): (1) Excess free fatty acids (FFAs) are esterified in AcylCoAs,
substrates involved in both synthetic and oxidative pathways. In the synthetic pathway, they are either stored as Triacylglycerols (TG) in lipid droplets or accumulated in
metabolites (DAGs, Ceramides) that act as signaling molecules and may interfere with normal cellular signaling. DAGs are associated with membrane translocation
and activation of Protein kinase C theta (PKC-θ), increased IRS1 serine/threonine phosphorylation and decreased insulin-stimulated IRS1 tyrosine phosphorylation,
whereas Ceramides impair insulin action by inhibiting protein kinase PKB/AKT (dark blue). In the oxidative pathway, AcylCoAs are imported into the mitochondria by
carnitine palmitoyltransferase-1 (CPT-1) shuttle and degraded via β-oxidation (in purple). (2) Insulin signaling pathway impaired by excess FFA (in green). Among FFAs,
saturated FAs (SFAs) stimulate the activation of several inflammatory pathways. (3) Receptor-mediated mechanisms, as those of Toll like receptors 2/4 (TLR 2/4),
activate serine kinases inhibitor kappaB kinase (IKK) and c-JUN NH2-terminal kinase (JNK). The activation of PKCθ also contributes to IKK and JNK activation.
Altogether, these kinases catalyze IRS1 serine phosphorylation and lead to a reduction of insulin-induced IRS1 tyrosine phosphorylation, impairing insulin action.
Moreover, IKK/NFkB axis (4) triggers expression of inflammatory genes with cytokines production (e.g., Tumor necrosis factor, TNFα), which in turn activate intracellular
pathways promoting insulin resistance development (in light blue). (5) SFAs enter the cellular membranes and incorporate into them reducing membrane fluidity and
(Continued)
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FIGURE 1 | Continued
creating or expanding subdomains rich in cholesterol and sphingolipids (lipid raft). They induce clustering and activation of cytosolic cSRC. cSRC activity is required
for JNK1 activation and inhibition of insulin signaling (in grey). (6) Endoplasmic reticulum stress (ER stress), induced by lipotoxicity, contributes to activate inflammatory
pathways and impair insulin signaling. (B): Putative role of mitochondria in development of IR. Mitochondrial dysfunction in presence of excess FFAs leads to
intramyocellular lipid accumulation due to impaired β-oxidation. Decreased mitochondrial mass, respiratory capacities and ATP synthesis have been found in obesity
and diabetes. Alternatively, excess FFA within mitochondria in the absence of increased energy demand stimulates oxidative stress with high rates of ROS production
and H2O2 emission and a shift to a more oxidized intracellular redox environment, ultimately leading to the development of IR.
2013), it is generally accepted that in this disease a
mitochondrial defect occurs, possibly secondary to a fat intake
increase.
MITOCHONDRIAL MORPHOLOGY AND
SKELETAL MUSCLE IR
It is well known that mitochondrial morphology is highly
variable, ranging between long tubular mitochondria and short
circular ones and it is maintained through a dynamic balance
between fusion and fission processes (Westermann, 2010, 2012),
which allow mitochondria to redistribute in a cell, exchange
contents and repair damaged mitochondria. These two opposing
processes are finely regulated by mitochondrial fusion proteins
mitofusins 1 and 2 (Mfn1 and Mfn2), and optic atrophy gene
1 (OPA1) (Cipolat et al., 2004; Palmer et al., 2011) and by
mitochondrial fission protein dynamin-related protein 1 (DRP1)
and fission protein 1 (Fis1) (Nunnari et al., 2002; Liesa et al.,
2009).
Several pieces of evidence suggested that mitochondrial
dynamic behavior play a key role in mitochondrial health,
bioenergetics function, quality control, and cell viability. Notably,
disruption of mitochondrial dynamics has been found in IR and
type 2 diabetes (Bach et al., 2003, 2005; Yu et al., 2006; Liesa and
Shirihai, 2013).
The group of Zorzano showed that decreased expression
of Mfn2 and altered expression of OPA1 participated in
obesity and type 2 diabetes development in both patients and
rodent models (Bach et al., 2003; Zorzano et al., 2009a,b,
2010; Hernández-Alvarez et al., 2010; Quirós et al., 2012). In
obese Zucker rats, skeletal muscle mitochondrial network was
reduced by 25% associated with a repression of Mfn2 (Bach
et al., 2003). In addition, skeletal muscle of obese subjects
and type 2 diabetic patients also showed a reduced expression
of Mfn2 mRNA and Mfn2 protein compared to lean subjects
(Bach et al., 2003, 2005). Mfn2 repression was detected in the
skeletal muscles of both obese and non-obese type 2 diabetic
patients (Bach et al., 2005). Notably, the expression of one
of the mitochondrial proteases involved in OPA1 processing,
presenilin-associated rhomboid-like (PARL), was also reduced in
diabetic animals. In humans, a positive linear correlation between
PARL mRNA levels and insulin sensitivity has been reported
(Walder et al., 2005). These data suggest multiple alterations
in mitochondrial fusion in IR. However, reduction of Mfn2
expression together with decreased mitochondrial size in skeletal
muscle in obesity and type 2 diabetes states allow proposing
a relevant role for Mfn2 in IR (Civitarese and Ravussin, 2008;
Zorzano et al., 2009a,b). In agreement with this suggestion, a
positive correlation between Mfn2 expression in skeletal muscle
and insulin sensitivity has been reported (Bach et al., 2005).
It is of interest that the involvement of Mfns in diet-induced
obesity via the regulation of leptin resistance and systemic energy
metabolism was also revealed (Dietrich et al., 2013; Schneeberger
et al., 2013; reviewed in Putti et al., 2015). Moreover, it has
been suggested that there is an association between increased
mitochondrial fission, mitochondrial bioenergetics and fat
induced-IR in skeletal muscle (Jheng et al., 2012). Indeed, in
differentiated C2C12 muscle cells mitochondrial fragmentation
and increased mitochondrion associated-DRP1 and Fis1 was
induced by excess palmitate and this fission phenotype was
associated with increased oxidative stress, loss of ATP production
and reduced insulin-stimulated glucose uptake. These authors
also found smaller and shorter mitochondria and increased
mitochondrial fission machinery in the skeletal muscle of mice
with genetic or diet-induced obesity. Furthermore, inhibition
of mitochondrial fission improved muscle insulin signaling
and systemic insulin sensitivity in obese mice (Jheng et al.,
2012).
A shift toward fission was also found in skeletal muscle
of HF diet (HFD)-induced obese mice by Liu et al. (2014).
Notably, these authors also faced the question of whether
mitochondrial dynamics exists in skeletal muscle in vivo. It
should be considered that mitochondria in skeletal muscle
are rigidly located between bundles of myofilaments in a
highly regular “crystal like” pattern (Vendelin et al., 2005) and
therefore, their motility and dynamics may be very restricted.
Liu et al. (2014) confirmed that mitochondria are dynamic
organelles in skeletal muscle in vivo, by demonstrating that they
exchange contents within the whole mitochondrial population
through nanotunneling-mediated mitochondrial fusion. In this
way, mitochondria can bypass the restriction of myofilament
and exchange mitochondrial matrix contents even if they are
distant. This dynamic communication among mitochondria in
skeletal muscle may protect from injury by preventing the
accumulation of detrimental metabolites. Liu et al. (2014) also
showed that this dynamic behavior was inhibited in skeletal
muscle of HFD–induced obese mice associated with decreased
Mfn2 and increased Fis1 and DRP1 expression compared to
normal diet fed mice. This impaired mitochondrial fusion in
skeletal muscle of HFD-induced obese mice was accompanied
with damaged mitochondrial respiratory function and decreased
ATP content. Therefore, the authors suggest that mitochondrial
dynamics play an important role in regulating mitochondrial
function, including respiration rate and ATP production (Liu
et al., 2014).
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DIETARY FAT SOURCE DIFFERENTLY
AFFECT SKELETAL MUSCLE IR AND
MITOCHONDRIAL MORPHOLOGY
It has been suggested that diverse dietary fat sources have
different effects on obesity and associated diseases development.
Saturated FA are well known to induce both obesity and related
disease, whereas omega 3 polyunsaturated FA (ω-3 PUFA) from
fish oil have been shown in many studies to protect against these
metabolic diseases (Xin et al., 2008; Gonzalez-Periz et al., 2009;
Abete et al., 2011). The effect of ω-3 PUFA on metabolic disease
has been extensively studied during the past three decades since
the first studies such as the one by Storlien et al. (1987) showing
that fish oil prevents IR induced by high-fat feeding in rats.
Further studies confirmed that ω-3 PUFA had an anti-obesity
effect and enhanced insulin sensitivity and glucose homeostasis
in rodent models of IR: the replacement of a small proportion of
the diet with ω-3 PUFAs from fish oil completely prevents the
development of skeletal muscle IR (Storlien et al., 1991; Fryer
et al., 1995). Recent studies hypothesized that ω-3 PUFAs protect
glucose tolerance, in part by preventing the accumulation of
bioactive lipid mediators that interfere with the insulin signaling
pathway (Lanza et al., 2013). Lanza et al. (2013) evaluated the
influence of dietary ω-3 PUFAs on mitochondrial physiology
and muscle lipid metabolites in the context of 10 weeks high-
fat feeding in mice. They found a lower content of long-chain
Acyl-CoAs and Ceramides in the presence of fish oil, whereas
mitochondrial oxidative capacity was similarly increased with
or without fish oil. Several studies have also indicated that ω-
3 PUFAs possess anti-inflammatory properties that prevent and
reverse the development of IR in mice which are fed a high-
fat diet in an adiponectin-dependent manner (Kalupahana et al.,
2010, 2011). On the other hand, unsaturated FA prevent c-Src
membrane partitioning and activation and block JNK activation
with consequent beneficial effects on insulin sensitivity (Holzer
et al., 2011). Considering the anti-inflammatory properties of ω-
3 PUFAs, in a recent study, we compared the effects of chronic
high-fish oil and high-lard diets on obesity-related inflammation
by evaluating serum and tissue adipokine levels and histological
features in insulin-sensitive tissues (white adipose tissue, liver
and skeletal muscle) (Lionetti et al., 2014b). We showed that
the replacement of lard (saturated FA) with fish oil (ω-3
PUFAs) in chronic high-fat feeding attenuated the development
of systemic and tissue inflammation. Indeed, compared with a
high-lard diet, a high-fish oil diet resulted in a lower degree
of systemic inflammation and IR that were associated with a
lower ectopic lipid depot, inflammation degree and IR in the
skeletal muscle (Lionetti et al., 2014b). In a further study on the
same experimental design, we confirmed that the replacement of
lard with fish oil in HF diet had preventive effects on obesity
and systemic inflammation and IR development as well as we
showed a fusion mitochondrial phenotype in association with
the improvement of IR in skeletal muscle (Lionetti et al., 2013).
As for preventive effects on obesity, body weight gain after
6 weeks of HF diet was lower in fish oil fed rats compared
to lard fed rats. As for skeletal muscle IR, we showed that
high-lard diet induced a defect in the skeletal muscle insulin
signaling pathway with a lower immune-reactivity to IRS1 and
pIRS (Tyr632), in agreement with other authors (Yaspelkis et al.,
2009; Yuzefovych et al., 2013). On the other hand, a high
fish oil diet elicited IRS1 and pIRS (Tyr632) immune-reactivity
similar to a control diet, in agreement with ameliorated systemic
insulin sensitivity (Lionetti et al., 2013). We cannot exclude
the possibility that the fish oil protective effect was due to
indirect effects of differences on adiposity. We also showed that
the beneficial effects of fish oil feeding on skeletal muscle IR
development was associated with changes in protein involved
in mitochondrial dynamic behavior, with a greater number of
immunoreactive fibers for Mfn2 and OPA1 proteins, as well as
a weaker immunostaining for DRP1 and Fis1 compared to high
lard feeding. Skeletal muscle electron microscopy observations
also suggested a prominent presence of fission events in high-
lard diet fed rats, and fusion events in high-fish oil diet fed rats
(Lionetti et al., 2013).
The finding on the effects of different dietary FA on
skeletal muscle mitochondrial fusion/fission proteins may be
associated with effects on inflammatory processes involved in
IR development. Indeed, Bach et al. (2005) suggested that TNF-
α inhibits Mfn2 gene expression in cells in culture, suggesting
that inflammatory parameters may play a regulatory role on
Mfn2. In agreement, we showed that pro-inflammatory dietary
saturated FA reduced Mfn2 expression and induced fission
phenotype in skeletal muscle (Lionetti et al., 2013). On the other
hand, the anti-inflammatory effect of dietary ω-3 PUFAs was
associated with no reduction in skeletal muscle Mfn2 content
and a tendency to mitochondrial fusion. This shift toward fusion
may be an adaptive mechanism to counteract cellular stress
induced by chronic HF diet, by allowing functional mitochondria
to complement dysfunctional mitochondria. In accordance,
myocytes cultured with docosahexaenoic acid exhibited a higher
mitochondrial mass with a higher proportion of large and
elongated mitochondria with downregulation of fission genes
DRP1 and Fis1 (Casanova et al., 2014).
The pro-fusion effect of ω-3 PUFAs dietary fat on skeletal
muscle mitochondria is in agreement with the results found in
liver mitochondria, where a shift toward mitochondrial fusion
phenotype was also suggested (Zhang et al., 2011; Lionetti et al.,
2014a).
The mechanism underlying fish oil/ω-3 PUFAs mitochondrial
fusion stimulation may involve receptor-mediated signaling
and/or lipid membrane composition, among other factors.
Indeed, ω-3 PUFAs are incorporated into cellular membranes
and may affect lipid-protein interactions as well as membrane
fluidity, and therefore the function of embedded proteins.
Recently, it has been suggested a role for ω-3 PUFAs in
reorganizing the composition of the mitochondrial membrane,
while promoting improvements in ADP sensitivity, determined
as mitochondrial responses during ADP titration (Herbst et al.,
2014). Moreover, it is well known that saturated FA incorporation
reduces membrane fluidity, whereas PUFA do not have such
effect (Clamp et al., 1997; Stulnig et al., 2001; Holzer et al., 2011).
Further studies are needed to elucidate these mechanisms.
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FIGURE 2 | Dietary fat source, mitochondrial dynamics and skeletal muscle IR. Diverse dietary fat sources induce different effects on mitochondrial
morphology/dynamics and IR development in skeletal muscle. Saturated fatty acids (SFA) elicit a shift toward fission processes (decreased Mfn2 and increased Fis1
and DRP1 expression) associated with reduced mitochondrial function, increased oxidative stress, lipid accumulation and IR development. -3 polyunsaturated fatty
acids (PUFAs) induce Mfn2 expression and fusion processes associated with less lipid accumulation and improved IR. IR, insulin resistance; Mfn2, mitofusin 2; DRP1,
dynamin-related protein 1; Fis1, fission protein 1.
CONCLUSIONS
Recent evidence highlighted an association between
mitochondrial morphology and IR development in skeletal
muscle. Few works on different dietary fat source started to
underline the different effect of saturated and ω-3 PUFAs
on skeletal muscle IR and mitochondrial protein involved in
dynamics behavior, suggesting an association between beneficial
protective effect of ω-3 PUFAs toward IR development and
mitochondrial fusion phenotype (Figure 2). However, it is
important to underline that most of the data present in literature
on skeletal muscle mitochondrial morphology and IR are from
associational studies. Therefore, there is an urgent requirement
for in vivo mechanistic studies to confirm the associational
relationship between mitochondrial morphology/dynamics and
IR development.
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